![[Search]](/static/images/search.gif){kind=small}
![[A-Z Index]](/static/images/az.gif){kind=small}
![[Contact]](/static/images/contact.gif){kind=small}
![[University of Cambridge]](/static/images/identifier2.gif){kind=small}
![[Talks.cam]](/static/images/talkslogosmall.gif)
Dr Teresa Lambe; The Jenner Institute, University of Oxford
Wednesday 18 July 2018, 12:00-13:00
Viral Vectored Vaccines against Influenza
⚠️ Important: If you would like to attend this seminar, please contact us to arrange site access
- 👤 Speaker: Dr Teresa Lambe; The Jenner Institute, University of Oxford
- 📅 Date & Time: Wednesday 18 July 2018, 12:00 - 13:00
- 📍 Venue: Babraham - The Cambridge Building; Kings Hedges Room
Questions? Contact
Bobbie Claxton
Abstract
Vaccines are efficacious and cost-effective preventative healthcare measures and a global mainstay in protecting millions from infectious disease. Dr. Lambe’s research interest lies in the development of efficacious vaccines, principally toward influenza and emerging pathogens. Viral vectors have become a vaccine platform of choice for many pathogens that have evaded conventional vaccination approaches. Dr Lambe will discuss the broad applicability of viral vectors as a platform technology with a focus on their use for the prevention of influenza-mediated disease.
Series This talk is part of the Babraham Seminar series.
Included in Lists
- Babraham Seminar
- Babraham - The Cambridge Building; Kings Hedges Room
- Graduate-Seminars
- se393's list
Note: Ex-directory lists are not shown.